| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709 [R. L. M., J. H.], and Battelle Pacific Northwest Laboratories, Richland, Washington 99352 [B. J. C., R. A. M.]
The carcinogenicity of inhaled 1,3-butadiene was evaluated in C57BL/6 x C3H F1 mice exposed to concentrations of this gas ranging from 6.25 to 625 ppm. Butadiene is a high production volume chemical, used mainly in the manufacture of synthetic rubber. In these 2-yr inhalation studies, a potent multisite carcinogenic response was observed, including neoplasms of the lung at concentrations as low as 6.25 ppm. Early occurrence and extensive development of lethal lymphocytic lymphomas in mice exposed to 625 ppm of butadiene reduced the number of animals at risk for the expression of later developing neoplasms at other sites; at lower exposure concentrations, dose responses were demonstrated for hemangiosarcomas of the heart and neoplasms of the lung, forestomach, Harderian gland, preputial gland, liver, mammary gland, and ovary. So far, no long-term studies on butadiene have been conducted at exposure concentrations that have not shown a carcinogenic response. In separate experiments with reduced exposure durations, butadiene induced neoplastic responses at multiple organ sites even after only 13 wk of exposure. Because of the correspondence between these animal data and recent epidemiology findings, there is a worldwide public health need to reevaluate current workplace exposure standards for 1,3-butadiene.
1 To whom requests for reprints should be addressed.
Received 7/26/89. Accepted 7/13/90.
This article has been cited by other articles:
|
|
 |
|
  M. Goggin, J. A. Swenberg, V. E. Walker, and N. Tretyakova Molecular Dosimetry of 1,2,3,4-Diepoxybutane-Induced DNA-DNA Cross-Links in B6C3F1 Mice and F344 Rats Exposed to 1,3-Butadiene by Inhalation Cancer Res., March 15, 2009; 69(6): 2479 - 2486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Lee, H. S. Kang, and D.-H. Han Ratios of N-(2,3,4-trihydroxybutyl) valine and N-(2-hydroxy-3-butenyl) valine formed hemoglobin adducts in female mice inhalation exposure with 1,3-butadiene Toxicology and Industrial Health, November 1, 2005; 21(10): 15 - 20. [Abstract] [PDF]
|
|
|
|
 |
|
 M.W. Powley, Y. Li, P.B. Upton, V.E. Walker, and J.A. Swenberg Quantification of DNA and hemoglobin adducts of 3,4-epoxy-1,2-butanediol in rodents exposed to 3-butene-1,2-diol Carcinogenesis, September 1, 2005; 26(9): 1573 - 1580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Melnick A Daubert Motion: A Legal Strategy to Exclude Essential Scientific Evidence in Toxic Tort Litigation Am J Public Health, July 1, 2005; 95(S1): S30 - S34. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Z. Abdel-Rahman, M. M. Ammenheuser, C. J. Omiecinski, J. K. Wickliffe, J. I. Rosenblatt, and J. B. Ward Jr. Variability in Human Sensitivity to 1,3-Butadiene: Influence of Polymorphisms in the 5'-Flanking Region of the Microsomal Epoxide Hydrolase Gene (EPHX1) Toxicol. Sci., May 1, 2005; 85(1): 624 - 631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Witschi Carcinogenic Activity of Cigarette Smoke Gas Phase and Its Modulation by Beta-Carotene and N-Acetylcysteine Toxicol. Sci., March 1, 2005; 84(1): 81 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Session 3: Risk Assessment Toxicol Pathol, October 1, 2004; 32(6): 733 - 735. [PDF]
|
|
|
|
 |
|
 C. L. Sprague and A. A. Elfarra DETECTION OF CARBOXYLIC ACIDS AND INHIBITION OF HIPPURIC ACID FORMATION IN RATS TREATED WITH 3-BUTENE-1,2-DIOL, A MAJOR METABOLITE OF 1,3-BUTADIENE Drug Metab. Dispos., August 1, 2003; 31(8): 986 - 992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Johnson and J. Huff Development of a multi-organ rat model for evaluating chemopreventive agents: efficacy of indole-3-carbinol-Certain health supplements may cause both carcinogenic and anticarcinogenic effects Carcinogenesis, October 1, 2002; 23(10): 1767 - 1768. [Full Text] [PDF]
|
|
|
|
|
|
A. Karlsson, P. Soderkvist, and S.-M. Zhuang Point Mutations and Deletions in the Znfn1a1/Ikaros Gene in Chemically Induced Murine Lymphomas Cancer Res., May 1, 2002; 62(9): 2650 - 2653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Kemper, R. J. Krause, and A. A. Elfarra Metabolism of Butadiene Monoxide by Freshly Isolated Hepatocytes from Mice and Rats: Different Partitioning between Oxidative, Hydrolytic, and Conjugation Pathways Drug Metab. Dispos., June 1, 2001; 29(6): 830 - 836. [Abstract] [Full Text]
|
|
|
|
|
|
S. Z. Abdel-Rahman, M. M. Ammenheuser, and J. B. Ward Jr Human sensitivity to 1,3-butadiene: role of microsomal epoxide hydrolase polymorphisms Carcinogenesis, March 1, 2001; 22(3): 415 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. C. Halmes, S. M. Roberts, J. K. Tolson, and C. J. Portier Reevaluating Cancer Risk Estimates for Short-Term Exposure Scenarios Toxicol. Sci., November 1, 2000; 58(1): 32 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-H. L. Hong, T. R. Devereux, R. L. Melnick, C. R. Moomaw, G. A. Boorman, and R. C. Sills Mutations of ras Protooncogenes and p53 Tumor Suppressor Gene in Cardiac Hemangiosarcomas from B6C3F1 Mice Exposed to 1,3-Butadiene for 2 Years Toxicol Pathol, July 1, 2000; 28(4): 529 - 534. [Abstract] [PDF]
|
|
|
|
|
|
N. J. van Sittert, H. J. J. J. Megens, W. P. Watson, and P. J. Boogaard Biomarkers of Exposure to 1,3-Butadiene as a Basis for Cancer Risk Assessment Toxicol. Sci., July 1, 2000; 56(1): 189 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.B. Hayes, L. Zhang, S. Yin, J.A. Swenberg, L. Xi, J. Wiencke, W.E. Bechtold, M. Yao, N. Rothman, R. Haas, et al. Genotoxic markers among butadiene polymer workers in China Carcinogenesis, January 1, 2000; 21(1): 55 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.n. Murg, M. Schuler, and D.A. Eastmond Evaluation of micronuclei and chromosomal breakage in the 1cen-q12 region by the butadiene metabolites epoxybutene and diepoxybutane in cultured human lymphocytes Mutagenesis, November 1, 1999; 14(6): 541 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Buckley, D. P. Coleman, J. P. Burgess, B. F. Thomas, L. T. Burka, and A. R. Jeffcoat Identification of Urinary Metabolites of Isoprene in Rats and Comparison with Mouse Urinary Metabolites Drug Metab. Dispos., July 1, 1999; 27(7): 848 - 854. [Abstract] [Full Text]
|
|
|
|
|
|
R. L. Melnick, R. C. Sills, C. J. Portier, J. H. Roycroft, B. J. Chou, S. L. Grumbein, and R. A. Miller Multiple organ carcinogenicity of inhaled chloroprene (2-chloro-1,3-butadiene) in F344/N rats and B6C3F1 mice and comparison of dose–response with 1,3-butadiene in mice Carcinogenesis, May 1, 1999; 20(5): 867 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.C. Sills, H.L. Hong, R.L. Melnick, G.A. Boorman, and T.R. Devereux High frequency of codon 61 K-ras A->T transversions in lung and Harderian gland neoplasms of B6C3F1 mice exposed to chloroprene (2-chloro-1,3-butadiene) for 2 years, and comparisons with the structurally related chemicals isoprene and 1,3-butadiene Carcinogenesis, April 1, 1999; 20(4): 657 - 662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Selzer and A. A. Elfarra In vitro reactions of butadiene monoxide with single- and double-stranded DNA: characterization and quantitation of several purine and pyrimidine adducts Carcinogenesis, February 1, 1999; 20(2): 285 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Kemper, A. A. Elfarra, and S. R. Myers Metabolism of 3-Butene-1,2-diol in B6C3F1 Mice. Evidence for Involvement of Alcohol Dehydrogenase and Cytochrome P450 Drug Metab. Dispos., September 1, 1998; 26(9): 914 - 920. [Abstract] [Full Text]
|
|
|
|
|
|
H. Iwata, Y. Nomura, and M. Enomoto Spontaneous Hemangioendothelial Cell Hyperplasia of the Heart in B6C3F1 Female Mice Toxicol Pathol, July 1, 1994; 22(4): 423 - 429. [Abstract] [PDF]
|
|
|
|
|
|
M.A. Mehlman and M.S. Legator Dangerous and Cancer-Causing Properties of Products and Chemicals in the Oil Refining and Petrochemical Industry - Part II: Carcinogenicity, Mutagenicity, and Developmental Toxicity of 1,3-Butadiene Toxicology and Industrial Health, May 1, 1991; 7(3): 207 - 222. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Rall Carcinogens and human health: Part 2 Science, January 4, 1991; 251(4989): 10 - 13. [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
